A phase III randomized trial of adding topical nitroglycerin to first-line chemotherapy for advanced nonsmall-cell lung cancer: the Australasian lung cancer trials group NITRO trial

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A DavidsonAustralasian Lung cancer Trials Group ALTG

Abstract

We sought to determine whether the substantial benefits of topical nitroglycerin with first-line, platinum-based, doublet chemotherapy in advanced nonsmall-cell lung cancer (NSCLC) seen in a phase II trial could be corroborated in a rigorous, multicenter, phase III trial. Patients starting one of five, prespecified, platinum-based doublets as first-line chemotherapy for advanced NSCLC were randomly allocated treatment with or without nitroglycerin 25 mg patches for 2 days before, the day of, and 2 days after, each chemotherapy infusion. Progression-free survival (PFS) was the primary end point. Accrual was stopped after the first interim analysis of 270 events. Chemotherapy was predominantly with carboplatin and gemcitabine (79%) or carboplatin and paclitaxel (18%). The final analysis included 345 events in 372 participants with a median follow-up of 33 months. Topical nitroglycerin had no demonstrable effect on PFS [median 5.0 versus 4.8 months, hazard ratio (HR) = 1.07, 95% confidence interval (CI) 0.86-1.32, P = 0.55], overall survival (median 11.0 versus 10.3 months, HR = 0.99, 95% CI 0.79-1.24, P = 0.94), or objective tumor response (31% versus 30%, relative risk = 1.03, 95% CI 0.82-1.29, P = 0.81). Headache, hypotension, ...Continue Reading

References

Jan 1, 1981·Journal of Chronic Diseases·W O SpitzerB R Catchlove
Aug 9, 2001·Annals of Medicine·R Rabin, F de Charro
Dec 26, 2001·Journal of the National Cancer Institute·N E MatthewsC H Graham
Apr 3, 2003·Journal of the National Cancer Institute·Eun-Jin YeoJong-Wan Park
Aug 7, 2003·Seminars in Radiation Oncology·Andy TrottiPhilip Rubin
Feb 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hiroyasu YasudaHidetada Sasaki
Nov 24, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hiroyasu YasudaMutsuo Yamaya
May 10, 2007·PharmacoEconomics·A Simon PickardAndrew Lloyd
Dec 23, 2008·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E A EisenhauerJ Verweij
May 28, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David R GandaraPhilip C Mack
Sep 15, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael L MaitlandMark J Ratain
Sep 9, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christopher G AzzoliUNKNOWN American Society of Clinical Oncology
Dec 23, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P N Lara, M W Redman
May 31, 2013·World Journal of Surgical Oncology·Sheetal Korde ChoudhariVaishali Joshi
Nov 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oriana YuLaurent Azoulay
Jan 1, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P N Lara, M W Redman

❮ Previous
Next ❯

Citations

Feb 20, 2016·Nitric Oxide : Biology and Chemistry·Ahmed El-SehemyYangXin Fu
Jul 1, 2016·Basic Research in Cardiology·Yuliya MikhedAndreas Daiber
Sep 8, 2016·European Journal of Nuclear Medicine and Molecular Imaging·Evelyn E C de JongAnne-Marie C Dingemans
Sep 20, 2017·Journal of the National Cancer Institute·Ahmed SalemCorinne Faivre-Finn
Oct 21, 2015·Nature Reviews. Clinical Oncology·Francesco BertoliniGauthier Bouche
Jul 14, 2016·Médecine sciences : M/S·Stéphanie PlenchetteAli Bettaieb
Aug 30, 2020·Antioxidants·Long Binh Vong, Yukio Nagasaki
May 6, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sanjay Popat
Feb 6, 2020·Clinical and Translational Radiation Oncology·Bart J T ReymenPhilippe Lambin
Jul 25, 2021·Cancers·Julien AncelValérian Dormoy
Aug 28, 2021·International Journal of Molecular Sciences·Sarra BouaouicheStéphanie Plenchette

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Corey LangerR F Ozols
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Giorgio ScagliottiN H Hanna
© 2021 Meta ULC. All rights reserved